Sub-Sensitivity to Long-Acting Bronchodilators (LABA).

Trial Profile

Sub-Sensitivity to Long-Acting Bronchodilators (LABA).

Phase of Trial: Phase II

Latest Information Update: 03 Apr 2017

At a glance

  • Drugs Budesonide/formoterol (Primary) ; Salmeterol/fluticasone propionate (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Jul 2011 Planned end date changed from 1 Jun 2011 to 1 Dec 2011 as reported by
    • 08 May 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top